<?xml version="1.0" encoding="utf-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:hal="http://hal.archives-ouvertes.fr/" xmlns:gml="http://www.opengis.net/gml/3.3/" xmlns:gmlce="http://www.opengis.net/gml/3.3/ce" version="1.1" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 http://api.archives-ouvertes.fr/documents/aofr-sword.xsd">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>HAL TEI export of hal-02309820</title>
      </titleStmt>
      <publicationStmt>
        <distributor>CCSD</distributor>
        <availability status="restricted">
          <licence target="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0 - Universal</licence>
        </availability>
        <date when="2026-05-02T23:05:21+02:00"/>
      </publicationStmt>
      <sourceDesc>
        <p part="N">HAL API Platform</p>
      </sourceDesc>
    </fileDesc>
  </teiHeader>
  <text>
    <body>
      <listBibl>
        <biblFull>
          <titleStmt>
            <title xml:lang="en">Target-Mediated Drug Disposition Population Pharmacokinetics Model of Alirocumab in Healthy Volunteers and Patients: Pooled Analysis of Randomized Phase I/II/III Studies</title>
            <author role="aut">
              <persName>
                <forename type="first">Nassim</forename>
                <surname>Djebli</surname>
              </persName>
              <idno type="halauthorid">1665988-0</idno>
              <affiliation ref="#struct-92706"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Jean-Marie</forename>
                <surname>Martinez</surname>
              </persName>
              <idno type="halauthorid">1667519-0</idno>
              <affiliation ref="#struct-92706"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Laura</forename>
                <surname>Lohan</surname>
              </persName>
              <idno type="halauthorid">1653503-0</idno>
              <affiliation ref="#struct-410122"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Sonia</forename>
                <surname>Khier</surname>
              </persName>
              <email type="md5">0bfc9c8f4eb33036f6e0e45c4a543cfe</email>
              <email type="domain">umontpellier.fr</email>
              <idno type="idhal" notation="string">sonia-khier</idno>
              <idno type="idhal" notation="numeric">177798</idno>
              <idno type="halauthorid" notation="string">46203-177798</idno>
              <idno type="ORCID">https://orcid.org/0000-0001-6712-8461</idno>
              <idno type="GOOGLE SCHOLAR">https://scholar.google.fr/citations?user=psUUILYAAAAJ&amp;hl=fr</idno>
              <affiliation ref="#struct-542518"/>
              <affiliation ref="#struct-410122"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Aurélie</forename>
                <surname>Brunet</surname>
              </persName>
              <idno type="halauthorid">1667529-0</idno>
              <affiliation ref="#struct-92706"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Fabrice</forename>
                <surname>Hurbin</surname>
              </persName>
              <idno type="halauthorid">1667530-0</idno>
              <affiliation ref="#struct-92706"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">David</forename>
                <surname>Fabre</surname>
              </persName>
              <idno type="halauthorid">157672-0</idno>
              <affiliation ref="#struct-92706"/>
            </author>
            <editor role="depositor">
              <persName>
                <forename>sonia</forename>
                <surname>khier</surname>
              </persName>
              <email type="md5">0bfc9c8f4eb33036f6e0e45c4a543cfe</email>
              <email type="domain">umontpellier.fr</email>
            </editor>
          </titleStmt>
          <editionStmt>
            <edition n="v1" type="current">
              <date type="whenSubmitted">2019-10-09 16:07:39</date>
              <date type="whenModified">2024-10-22 12:18:03</date>
              <date type="whenReleased">2019-10-10 14:33:34</date>
              <date type="whenProduced">2017-10</date>
              <date type="whenEndEmbargoed">2019-10-09</date>
              <ref type="file" target="https://hal.science/hal-02309820v1/document">
                <date notBefore="2019-10-09"/>
              </ref>
              <ref type="file" subtype="greenPublisher" n="1" target="https://hal.science/hal-02309820v1/file/Djebli_et_al-2017-Clinical_Pharmacokinetics.pdf" id="file-2309820-2227678">
                <date notBefore="2019-10-09"/>
              </ref>
              <ref type="externalLink" target="https://link.springer.com/content/pdf/10.1007%2Fs40262-016-0505-1.pdf"/>
            </edition>
            <respStmt>
              <resp>contributor</resp>
              <name key="794639">
                <persName>
                  <forename>sonia</forename>
                  <surname>khier</surname>
                </persName>
                <email type="md5">0bfc9c8f4eb33036f6e0e45c4a543cfe</email>
                <email type="domain">umontpellier.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>
            <distributor>CCSD</distributor>
            <idno type="halId">hal-02309820</idno>
            <idno type="halUri">https://hal.science/hal-02309820</idno>
            <idno type="halBibtex">djebli:hal-02309820</idno>
            <idno type="halRefHtml">&lt;i&gt;Clinical Pharmacokinetics&lt;/i&gt;, 2017, 56 (10), pp.1155-1171. &lt;a target="_blank" href="https://dx.doi.org/10.1007/s40262-016-0505-1"&gt;&amp;#x27E8;10.1007/s40262-016-0505-1&amp;#x27E9;&lt;/a&gt;</idno>
            <idno type="halRef">Clinical Pharmacokinetics, 2017, 56 (10), pp.1155-1171. &amp;#x27E8;10.1007/s40262-016-0505-1&amp;#x27E9;</idno>
            <availability status="restricted">
              <licence target="https://about.hal.science/hal-authorisation-v1/">HAL Authorization<ref corresp="#file-2309820-2227678"/></licence>
            </availability>
          </publicationStmt>
          <seriesStmt>
            <idno type="stamp" n="INSERM">INSERM - Institut national de la santé et de la recherche médicale</idno>
            <idno type="stamp" n="FNCLCC" corresp="INSERM">UNICANCER</idno>
            <idno type="stamp" n="VALDAURELLE" corresp="FNCLCC">CRLC Val d'Aurelle - Paul Lamarque</idno>
            <idno type="stamp" n="BS">Biologie-Santé</idno>
            <idno type="stamp" n="UNIV-MONTPELLIER">Université de Montpellier</idno>
            <idno type="stamp" n="IRCM" corresp="UNIV-MONTPELLIER">Institut de Recherche en Cancérologie de Montpellier</idno>
            <idno type="stamp" n="UM-2015-2021" corresp="UNIV-MONTPELLIER">Université de Montpellier (2015-2021)</idno>
          </seriesStmt>
          <notesStmt>
            <note type="audience" n="2">International</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
          </notesStmt>
          <sourceDesc>
            <biblStruct>
              <analytic>
                <title xml:lang="en">Target-Mediated Drug Disposition Population Pharmacokinetics Model of Alirocumab in Healthy Volunteers and Patients: Pooled Analysis of Randomized Phase I/II/III Studies</title>
                <author role="aut">
                  <persName>
                    <forename type="first">Nassim</forename>
                    <surname>Djebli</surname>
                  </persName>
                  <idno type="halauthorid">1665988-0</idno>
                  <affiliation ref="#struct-92706"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Jean-Marie</forename>
                    <surname>Martinez</surname>
                  </persName>
                  <idno type="halauthorid">1667519-0</idno>
                  <affiliation ref="#struct-92706"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Laura</forename>
                    <surname>Lohan</surname>
                  </persName>
                  <idno type="halauthorid">1653503-0</idno>
                  <affiliation ref="#struct-410122"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Sonia</forename>
                    <surname>Khier</surname>
                  </persName>
                  <email type="md5">0bfc9c8f4eb33036f6e0e45c4a543cfe</email>
                  <email type="domain">umontpellier.fr</email>
                  <idno type="idhal" notation="string">sonia-khier</idno>
                  <idno type="idhal" notation="numeric">177798</idno>
                  <idno type="halauthorid" notation="string">46203-177798</idno>
                  <idno type="ORCID">https://orcid.org/0000-0001-6712-8461</idno>
                  <idno type="GOOGLE SCHOLAR">https://scholar.google.fr/citations?user=psUUILYAAAAJ&amp;hl=fr</idno>
                  <affiliation ref="#struct-542518"/>
                  <affiliation ref="#struct-410122"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Aurélie</forename>
                    <surname>Brunet</surname>
                  </persName>
                  <idno type="halauthorid">1667529-0</idno>
                  <affiliation ref="#struct-92706"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Fabrice</forename>
                    <surname>Hurbin</surname>
                  </persName>
                  <idno type="halauthorid">1667530-0</idno>
                  <affiliation ref="#struct-92706"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">David</forename>
                    <surname>Fabre</surname>
                  </persName>
                  <idno type="halauthorid">157672-0</idno>
                  <affiliation ref="#struct-92706"/>
                </author>
              </analytic>
              <monogr>
                <idno type="halJournalId" status="VALID">11818</idno>
                <idno type="issn">0312-5963</idno>
                <idno type="eissn">1179-1926</idno>
                <title level="j">Clinical Pharmacokinetics</title>
                <imprint>
                  <publisher>Springer Verlag</publisher>
                  <biblScope unit="volume">56</biblScope>
                  <biblScope unit="issue">10</biblScope>
                  <biblScope unit="pp">1155-1171</biblScope>
                  <date type="datePub">2017-10</date>
                </imprint>
              </monogr>
              <idno type="doi">10.1007/s40262-016-0505-1</idno>
            </biblStruct>
          </sourceDesc>
          <profileDesc>
            <langUsage>
              <language ident="en">English</language>
            </langUsage>
            <textClass>
              <classCode scheme="halDomain" n="sdv.sp.pharma">Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology</classCode>
              <classCode scheme="halDomain" n="sdv.sp.med">Life Sciences [q-bio]/Pharmaceutical sciences/Medication</classCode>
              <classCode scheme="halDomain" n="sdv.sp">Life Sciences [q-bio]/Pharmaceutical sciences</classCode>
              <classCode scheme="halDomain" n="stat.ap">Statistics [stat]/Applications [stat.AP]</classCode>
              <classCode scheme="halTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halOldTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halTreeTypology" n="ART">Journal articles</classCode>
            </textClass>
            <abstract xml:lang="en">
              <p>Background and Objective Proprotein convertase subtil-isin/kexin type 9 inhibition with monoclonal antibodies such as alirocumab significantly reduces low-density lipoprotein-cholesterol levels ± other lipid-lowering therapies. We aimed to develop and qualify a population pharmacokinetics (PopPK) model for alirocumab in healthy subjects and patients, taking into account the mecha-nistic target-mediated drug disposition (TMDD) process. Methods This TMDD model was developed using a subset of the alirocumab clinical trial database, including nine phase I/II/III studies (n = 527); the model was subsequently expanded to a larger data set of 13 studies (n = 2870). Potential model parameters and covariate relationships were explored, and predictive ability was qualified using a visual predictive check. Results The TMDD model was built using the quasi-steady-state approximation. The final TMDD-quasi-steady-state model included a significant relationship between distribution volume of the central compartment and disease state: distribution volume of the central compartment was 1.56-fold higher in patients vs. healthy subjects. Separately, application of the model to the expanded data set revealed a significant relationship between linear clearance and statin co-administration: linear clearance was 1.27-fold higher with statins. The good predictive performance of the TMDD model was assessed based on graphical and numerical quality criteria, together with the visual predictive check and comparison of the predictions to those from a PopPK model with parallel linear and Michaelis-Menten clearances (i.e., simplification of the TMDD PopPK model). Conclusions This mechanistic TMDD PopPK model integrates the interaction of alirocumab with its target and accurately predicts both alirocumab and total proprotein convertase subtilisin/kexin type 9 concentrations in healthy subjects and patients. Electronic supplementary material The online version of this article (</p>
            </abstract>
          </profileDesc>
        </biblFull>
      </listBibl>
    </body>
    <back>
      <listOrg type="structures">
        <org type="laboratory" xml:id="struct-92706" status="VALID">
          <orgName>Sanofi-Aventis R&amp;D</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-300501" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-410122" status="OLD">
          <idno type="ISNI">0000000120970141</idno>
          <idno type="ROR">https://ror.org/051escj72</idno>
          <orgName>Université de Montpellier</orgName>
          <orgName type="acronym">UM</orgName>
          <date type="end">2021-12-31</date>
          <desc>
            <address>
              <addrLine>163 rue Auguste Broussonnet - 34090 Montpellier</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.umontpellier.fr/</ref>
          </desc>
        </org>
        <org type="laboratory" xml:id="struct-542518" status="OLD">
          <idno type="ISNI">0000000406246108</idno>
          <idno type="ROR">https://ror.org/03capj968</idno>
          <orgName>Institut de Recherche en Cancérologie de Montpellier</orgName>
          <orgName type="acronym">IRCM - U1194 Inserm - UM</orgName>
          <date type="start">2015-01-01</date>
          <date type="end">2021-12-31</date>
          <desc>
            <address>
              <addrLine>Campus Val d’Aurelle - Parc Euromédecine - 208, rue des Apothicaires 34298 Montpellier</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://ircm.fr/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-300222" type="direct"/>
            <relation name="U1194" active="#struct-303623" type="direct"/>
            <relation active="#struct-410122" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-300501" status="VALID">
          <orgName>SANOFI Recherche</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
          </desc>
        </org>
        <org type="institution" xml:id="struct-300222" status="VALID">
          <orgName>CRLCC Val d'Aurelle - Paul Lamarque</orgName>
          <desc>
            <address>
              <addrLine>34298 Montpellier</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.valdaurelle.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-303623" status="VALID">
          <idno type="IdRef">026388278</idno>
          <idno type="ROR">https://ror.org/02vjkv261</idno>
          <orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
          <orgName type="acronym">INSERM</orgName>
          <desc>
            <address>
              <addrLine>101, rue de Tolbiac, 75013 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.inserm.fr</ref>
          </desc>
        </org>
      </listOrg>
    </back>
  </text>
</TEI>